Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant-Reference-Cited by-同舟云学术

Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant

Published:2014-09-17 Issue:5 Volume:23 Page:711-714
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

Potjer Thomas P,Kranenburg Heidi E,Bergman Wilma,de Vos tot Nederveen Cappel Wouter H,van Monsjou Hester S,Barge-Schaapveld Daniela Q C M,Vasen Hans F A

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics

Link

http://www.nature.com/articles/ejhg2014187.pdf

Reference19 articles.

1. Hayward NK : Genetics of melanoma predisposition. Oncogene 2003; 22: 3053–3062.

2. Goldstein AM : Familial melanoma, pancreatic cancer and germline CDKN2A mutations. Hum Mutat 2004; 23: 630.

3. Gruis NA, van der Velden PA, Sandkuijl LA et al.. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 1995; 10: 351–353.

4. Vasen HF, Gruis NA, Frants RR, van der Velden PA, Hille ET, Bergman W : Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 2000; 87: 809–811.

5. Vasen HF, Wasser M, van Mil A et al.. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. Gastroenterology 2011; 140: 850–856.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review;Cancers;2023-12-21

2. Psychosocial issues of individuals undergoing surveillance for increased risk of melanoma and pancreatic cancer due to a germline CDKN2A variant: A focus group study;Journal of Genetic Counseling;2023-10-25

3. Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer;JCO Precision Oncology;2022-11

4. Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant Carriers;JNCI Cancer Spectrum;2022-10-21

5. Melanoma‐specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non‐carriers;Journal of the European Academy of Dermatology and Venereology;2022-10